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Other names: TML1 
Location: 14q32.13 
Local order: centromere - TCL6 (TNG1 and TNG2) - 
TCL1B - TCL1A - telomere 
DNA/RNA 
Description 
6.5 kb TCL1B cDNA. 4 exons (181, 171, 69, 697 bp); 
centromere - exons 1 to 4 - telomere orientation; only 
the first three exons are coding. Located 15-16 kb 
centromeric of TCL1A. 
Transcription 
TCL1B transcripts detected by RT-PCR or Northern 
blot in fetal tissues (liver, thymus, spleen, and kidney) 
and in testis, placenta, peripheral blood lymphocytes, 
kidney, tonsil, spleen, and bone marrow. 
Pseudogene 
Localized to 5q12-5q13, lacks an initiating ATG and 
introns and has a stop codon in the middle of the ORF. 
Protein 
Description 







Undefined in vivo but binds and coactivates AKT 
(protein kinase B) in vitro and in transfected cell lines. 
Homology 
30% identical to TCL1A, 60% similar to TCL1A. 
36% identical to MTCP1, 63% similar to MTCP1. 
Implicated in 
Expression in rare mature T cell 
leukemias carrying t(14;14)(q11;q32.1) 
causing a TCRalpha/delta- TCL1A 
/TCL1B translocation 
Disease 
May be upregulated in T-cell prolymphocytic leukemia 
(T-PLL) with t(14;14)(q11;q32.1) and in Burkitt 
lymphoma 
Oncogenesis 
TCL1 over expression by chromosomal rearrangement 
is a critical oncogenetic mechanism in T-PLL; a role 
for TCL1B over expression in oncogenesis is not yet 
shown. 
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